Cantor Equity Partners II, Inc.

$12.14 ▼ -3.8%
2026-06-06 07:09:00
NGM: CEPT

Explore Cantor Equity Partners II, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$385.92 M
Current Price
$12.14
52W High / Low
$14.05 / $10.32
Stock P/E
22,027.38
Book Value
$7.87
Dividend Yield
ROCE
-0.76%
ROE
0.02%
Face Value
EPS
$0.02
Exp Qtr EPS
Sector
Financial Services

CEPT — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Balance sheet leverage appears manageable.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Current ratio suggests tighter short-term liquidity.
  • Operating margin is thin.
  • Net margin is relatively low.
  • Valuation is rich on a P/E basis.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Twenty One Capital, Inc. $5.64 $4.18 B -69.16% $47.8 / $5.61 $5.28
2. A Paradise Acquisition Corp $2.46 60.18 $2.23 B -0.51% -13.33% $14 / $2.35 $-0.28
3. Willow Lane Acquisition Corp $29.14 396.12 $1.36 B -1.53% 2.71% $42 / $10.13 $7.39
4. Cantor Equity Partners III, Inc. $6.91 318.01 $1.21 B -0.81% 1.36% $15.3 / $6.5 $7.98
5. Armada Acquisition Corp. III $9.95 $728.12 M -9.52% $10.91 / $9.74 $2.08
6. Drugs Made In America Acquisition II Corp. $10.08 74.8 $642.1 M 1.72% $10.08 / $9.86 $35.56
7. Bold Eagle Acquisition Corp. $10.63 64.99 $616.35 M -0.38% 3.65% $10.95 / $10.34 $8.33

Quarterly Results

Figures shown in M / B

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales0 M0 M0 M0 M0 M
Operating Profit-1.53 M-0.15 M-0.14 M-0.03 M-0.02 M
Net Profit-3.76 M2.41 M1.39 M-0.03 M-0.02 M
EPS in Rs-0.150.10.06-0-0-0

Profit & Loss

Figures shown in M / B

2025202420232022
Sales0 M0 M0 M0 M
Operating Profit-1.85 M-0.07 M-0 M-0.01 M
Net Profit0.02 M-0.07 M-0 M-0.01 M
EPS in Rs0-0-0-0

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets246.84 M0.11 M0 M0.01 M
Total Liabilities6.25 M0.17 M0 M0 M
Equity240.59 M-0.07 M0 M0.01 M
Current Assets0.17 M0 M0 M0.01 M
Current Liabilities1.64 M0.17 M0 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF0.04 M-0.08 M0 M0 M
Investing CF-240 M0 M
Financing CF239.98 M0.08 M0 M
Free CF0.04 M-0.08 M0 M0 M
Capex

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2025202420232022
Revenue Growth %
Earnings Growth %124.78%-1935.77%44.79%
Profit Margin %
Operating Margin %
Gross Margin %
EBITDA Margin %

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund Mutual Fund 0.01 M $0.16 M 0% 2026-02-28
Saba Capital Income & Opportunities Fund Mutual Fund 0.04 M $0.4 M 0% 2026-01-31
Saba Capital Income & Opportunities Fund II Mutual Fund 0.02 M $0.2 M 0% 2026-01-31
Harraden Circle Investments, LLC Institutional 2.44 M $26.8 M 0.1% 2025-12-31
Alyeska Investment Group, L.p. Institutional 1.76 M $19.36 M 0.07% 2025-12-31
Highbridge Capital Management, LLC. Institutional 1.32 M $14.51 M 0.05% 2025-12-31
Governors Lane LP Institutional 1.17 M $12.84 M 0.05% 2025-12-31
Shaw D.E. & Co., Inc. Institutional 0.7 M $7.73 M 0.03% 2025-12-31
Two Sigma Investments, LP Institutional 0.66 M $7.3 M 0.03% 2025-12-31
Toronto Dominion Bank Institutional 0.62 M $6.86 M 0.03% 2025-12-31
Healthcare of Ontario Pension Plan Trust Fund Institutional 0.5 M $5.49 M 0.02% 2025-12-31
Magnetar Financial LLC Institutional 0.46 M $5.05 M 0.02% 2025-12-31
Dld Asset Management, Lp Institutional 0.4 M $4.39 M 0.02% 2025-12-31
INVESTMENT MANAGERS SERIES TRUST II-First Trust Merger Arbitrage Fund Mutual Fund 0.15 M $1.6 M 0.01% 2025-12-31
INVESTMENT MANAGERS SERIES TRUST II-First Trust Multi-Strategy Fund Mutual Fund 0.03 M $0.3 M 0% 2025-12-31

Frequently Asked Questions — Cantor Equity Partners II, Inc.

Will Cantor Equity Partners II, Inc. stock hit $15 in 2026?

Cantor Equity Partners II, Inc. (CEPT) is currently trading at $12.14, with a 52-week range of $10.32 to $14.05. Reaching the $15 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $16.0 for Cantor Equity Partners II, Inc., with a None rating, and the most bullish analysts see the stock reaching as high as $16.0. Whether Cantor Equity Partners II, Inc. can reach $15 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Financial Services space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, CEPT has delivered a 3.8% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the CEPT Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Cantor Equity Partners II, Inc. stock worth buying at $12.14?

Whether Cantor Equity Partners II, Inc. (CEPT) is worth buying at $12.14 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Cantor Equity Partners II, Inc. trades at a Price-to-Earnings (P/E) ratio of 22027.4x, which can be compared against other Financial Services companies to assess whether the stock is expensive or attractively priced relative to its peers.

Profitability & efficiency: Cantor Equity Partners II, Inc. has a Return on Capital Employed (ROCE) of -0.8%, which reflects modest capital efficiency.

Financial health: Review the balance sheet section on StockSifting for the latest debt levels, cash reserves, and liquidity ratios.

Analyst view: The Wall Street consensus recommendation for CEPT is currently None, with a mean price target of $16.0 based on 1 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Cantor Equity Partners II, Inc. (CEPT) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $16.0 for Cantor Equity Partners II, Inc. (CEPT), aggregated from 1 analyst ratings. The overall analyst recommendation is None.

The price target range spans from $16.0 on the bearish end to $16.0 on the most optimistic projection, with a median target of $16.0. This wide range reflects differing views on Cantor Equity Partners II, Inc.'s growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the CEPT analysis page on StockSifting.

Is Cantor Equity Partners II, Inc. overvalued at a P/E ratio of 22027.4x?

Cantor Equity Partners II, Inc. (CEPT) currently has a Price-to-Earnings (P/E) ratio of 22027.4x, meaning investors are paying $22027.4 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:

Sector context: The Financial Services sector tends to command higher valuation multiples when growth expectations are elevated. A 22027.4x P/E is on the higher end, suggesting the market is pricing in continued strong earnings growth — any disappointment in future earnings could lead to a multiple contraction.

Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation. Cantor Equity Partners II, Inc.'s ROCE of -0.8% suggests it has moderate capital returns.

Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of CEPT's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.

What will Cantor Equity Partners II, Inc. stock be worth in 2029?

Projecting Cantor Equity Partners II, Inc. (CEPT)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

Based on CEPT's historical 5-year Compound Annual Growth Rate (CAGR) of 3.8%, if that rate of growth were to continue, the stock could reach approximately $14 by 2029 — up from its current price of $12.14. This projection assumes the historical CAGR holds, which depends on Cantor Equity Partners II, Inc. sustaining its revenue growth, maintaining profit margins, and the market continuing to reward it at a similar valuation multiple.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the CEPT Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.